World Health Organization. Global hepatitis report 2024: action for access in low-and middle-income countries. World Health Organization; 2024.
Du Z, Yin S, Liu B, Zhang W, Sun J, Fang M, Xu Y, Hua K, Tu P, Zhang G. Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma. Heliyon. 2023;9(5):e16083.
Article CAS PubMed PubMed Central Google Scholar
Weber S, Unger K, Alunni-Fabbroni M, Hirner-Eppeneder H, Öcal E, Zitzelsberger H, et al. Metabolomic analysis of human cirrhosis and hepatocellular carcinoma: a pilot study. Dig Dis Sci. 2024;69(7):2488–501.
Article CAS PubMed PubMed Central Google Scholar
Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451–9.
Article CAS PubMed PubMed Central Google Scholar
Hong C, Liang S, Li Z, Li R, Zhu H, He M, et al. Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine. J Transl Med. 2025;23(1):769–80.
Article CAS PubMed PubMed Central Google Scholar
Xiao Y, Ma D, Yang Y, Yang F, Ding J, Gong Y, Jiang L, Ge L, Wu S, Yu Q, Zhang Q, Bertucci F, Sun Q, Hu X, Li D, Shao Z, Jiang Y. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell Res. 2022;32(5):477–90.
Article CAS PubMed PubMed Central Google Scholar
Pinu FR, Goldansaz SA, Jaine J. Translational metabolomics: current challenges and future opportunities. Metabolites. 2019;9(6):08.
Wang Y, Zhu Z, Deng L, Cheng KK, Guo F, Lin G, Raftery D, Dong J. Multiscale synergy networks offer insights into disease and comorbidity mechanisms. Anal Chem. 2025;97(6):3633–42.
Article CAS PubMed Google Scholar
Ramautar R, Berger R, Greef J, Hankemeier T. Human metabolomics: strategies to understand biology. Curr Opin Chem Biol. 2013;17(5):841–6.
Article CAS PubMed Google Scholar
Guo F, Lin G, Dong L, Cheng KK, Deng L, Xu X, Raftery D, Dong J. Concordance-based batch effect correction for large-scale metabolomics. Anal Chem. 2023;95(18):7220–8.
Article CAS PubMed Google Scholar
Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7(1):391.
Article CAS PubMed PubMed Central Google Scholar
La Merrill MA, Smith MT, McHale CM, Heindel JJ, Atlas E, Cave MC, et al. Consensus on the key characteristics of metabolism disruptors. Nat Rev Endocrinol. 2025;21(4):245–61.
Broadhurst DI, Kell DB. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics. 2006;2(4):171–96.
Vinaixa M, Samino S, Saez I, Duran J, Guinovart JJ, Yanes O. A guideline to univariate statistical analysis for LC/MS-based untargeted metabolomics-derived data. Metabolites. 2012;2(4):775–95.
Article CAS PubMed PubMed Central Google Scholar
Szymanska E, Saccenti E, Smilde AK, Westerhuis JA. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics. 2012;8(Suppl 1):3–16.
Article CAS PubMed Google Scholar
Edgell SE, Noon SM. Effect of violation of normality on the t test of the correlation coefficient. Psychol Bull. 1984;95(3):576–83.
Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2(11):2692–703.
Article CAS PubMed Google Scholar
Lin C, Chen Z, Zhang L, Wei Z, Cheng KK, Liu Y, et al. Deciphering the metabolic perturbation in hepatic alveolar echinococcosis: a 1H NMR-based metabolomics study. Parasit Vectors. 2019;12(1):300.
Article PubMed PubMed Central Google Scholar
Willcott MB. MestRe Nova. J Am Chem Soc. 2009;131(36):13180.
Mehmood T, Ahmed B. The diversity in the applications of partial least squares: an overview. J Chemometr. 2016;30(1):4–17.
Blondel VD, Guillaume JL, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J Stat Mech-Theory E. 2008;10:10008.
Thevenot EA, Roux A, Xu Y, Ezan E, Junot C. Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J Proteome Res. 2015;14(8):3322–35.
Article CAS PubMed Google Scholar
Bai C, Wang H, Dong D, Li T, Yu Z, Guo J, et al. Urea as a by-product of ammonia metabolism can be a potential serum biomarker of hepatocellular carcinoma. Front Cell Dev Biol. 2021;9:650748.
Article PubMed PubMed Central Google Scholar
Zeisel SH. Choline: an important nutrient in brain development, liver function and carcinogenesis. J Am Coll Nutr. 1992;11(5):473–81.
Article CAS PubMed Google Scholar
Ewald JD, Zhou G, Lu Y, Kolic J, Ellis C, Johnson JD, Macdonald PE, Xia J. Web-based multi-omics integration using the analyst software suite. Nat Protoc. 2024;19(5):1467–97.
Article CAS PubMed Google Scholar
Lai HS, Lee JC, Lee PH, Wang ST, Chen WJ. Plasma free amino acid profile in cancer patients. Semin Cancer Biol. 2005;15(4):267–76.
Article CAS PubMed Google Scholar
Tessari P, Kiwanuka E, Vettore M, Barazzoni R, Zanetti M, Cecchet D, Orlando R. Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion. Am J Physiol Gastrointest Liver Physiol. 2008;295(3):G598–604.
Article CAS PubMed Google Scholar
Dejong CHC, van de Poll MCG, Soeters PB, Jalan R, Olde Damink SWM. Aromatic amino acid metabolism during liver failure. J Nutr. 2007;137(6 Supp 1):1579S-1585S.
Article CAS PubMed Google Scholar
Shen C, Jiang X, Li M, Luo Y. Hepatitis virus and hepatocellular carcinoma: recent advances. Cancers. 2023;15(2):533.
Article CAS PubMed PubMed Central Google Scholar
Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, et al. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep. 2015;5:8421.
Article CAS PubMed PubMed Central Google Scholar
Li Z, Wang F, Liang B, Su Y, Sun S, Xia S, et al. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduct Target Ther. 2020;5:280.
Article CAS PubMed PubMed Central Google Scholar
Locasale JW. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer. 2013;13(8):572–83.
Comments (0)